Objectives: The adoption of endovascular aortic aneurysm repair (EVAR) over the past 15 years has led to significantly decreased length of stay as well as hospital resource utilization. Currently, most patients are admitted to hospital post-EVAR, however, there are no standard observation periods, and timing of discharge is based on clinical judgment. The aim of this study was to confirm the safety and feasibility of performing EVAR as an outpatient surgery.
Objectives: Patient safety indicators (PSI) are measures that screen for adverse events that may be amenable to prevention by changes at the system and/or provider level. PSI-04 (failure to rescue [FTR] ) is death following major complications and is a significant driver of 30-day mortality after open abdominal aortic aneurysm (OAAA) repair. Substantial hospital variation exists, and the association of hospital volume with different PSIs antecedent to FTR is unknown. We sought to determine how hospital volume influences FTR and 30-day mortality, as well as identify how these attributes further impact variation in PSIs preceding these mortality events.
Methods: The University Health Consortium was queried for all OAAA repairs (elective: n ¼ 2827; nonelective: n ¼ 1622) performed from 2012 to 2014. Hospitals were categorized into volume quartiles, and presentation (elective vs nonelective) was factored into all analyses. Risk-adjusted rates of PSIs, FTR, and 30-day mortality were determined. Logistic regression was used to identify which PSIs were independently associated with postoperative FTR and/or 30-day death. Hospital volume effects on PSIs and FTR were determined to understand the proportionate reduction in random effect variance that influences these parameters.
Results: The overall FTR and/or 30-day mortality rate was 9.1% (n ¼ 414). A significant volume-outcome relationship affecting FTR/30-day mortality was identified across the University Health Consortium (Fig) . The lowest quartile hospitals were significantly more likely to have a (Table) . The most important preoperative predictors of FTR/30-day mortality were nonelective presentation (OR, 4.1; 95% CI, 3.1-5.5; P < .0001), congestive heart failure (OR, 2.1; 95% CI, 1.3-3.5; P ¼ .003), valve disease (OR, 2; 95% CI, 1.2-3.2; P ¼ .008), cerebrovascular disease (OR, 1.9; 95% CI, 1.1-3.5; P ¼ .03), age >75 (OR, 1.8; 95% CI, 1.3-2.3; P ¼ .01), arrhythmia (OR, 1.5; 95% CI, 0.9-2.3; P ¼ .02), annual case volume <15 (OR, 1.4; 95% CI, 1.2-1.5; P ¼ .01), and coagulopathy (OR, 1.2; 95% CI, 1-2.6; P ¼ .03; area under the curve, 0.78).
Conclusions: The volume-outcome relationship influencing FTR/30-day mortality risk is significantly impacted by rates of various PSIs. These findings further support the concept of regionalizing AAA care nationally. Importantly, the most vulnerable patients can be identified preoperatively, allowing opportunities for change to processes of care that may reduce the likelihood of preventable adverse events that precede postoperative mortality.
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Three-Year Outcomes of the IMPROVE Trial for Ruptured Abdominal Aortic Aneurysm
Janet Powell, MD, IMPROVE Trial Investigators. Imperial College London, London, United Kingdom
Objectives: This study compared mortality and reinterventions between patients randomized to either an endovascular strategy or open repair 3 years previously and evaluated how these outcomes were influenced by preoperative aortoiliac morphology.
Methods: Multicenter randomized controlled trial (ISRCTN 48334791), recruiting 613 patients between September 2009 and July 2013: computed tomography (CT) scans were assessed in a core laboratory. Patients were followed up by trial centers, with deaths reported by national registers and reinterventions taking place at nontrial centers obtained from audit and/or administrative databases. After patient discharge, reinterventions were categorized as arterial, laparotomyrelated, or other and scored for clinical severity by investigator consensus and patient-perceived severity. The influence of preoperative aortoiliac morphology on reinterventions was assessed. Statistical analysis was according to prespecified plans approved by the trial writing committee (Table) .
Results: After 3 years, five patients had been lost to follow-up due to emigration, and 151 of 313 (48%) and 165 of 295 (56%) patients had died in the endovascular strategy and open repair groups, respectively (c 2 P ¼ .058). There was a similar quality-adjusted life-year benefit for the endovascular strategy group at 3 years. In the endovascular strategy group, there were 130 reinterventions in 76 of 316 patients. In the open repair group, there were 113 reinterventions in 68 of 297 patients. Over the 3 years of follow-up, the rate at which reinterventions occurred were similar in the 2 groups (24.0 and 26.8 per 100 person-years in the endovascular strategy and open repair groups, respectively). Between 3 months and 3 years the reintervention rate was low but twice as high in the endovascular strategy group (8.4 vs 4.3 per 100 personyears), although many of these reinterventions were minor (severity score to be presented). From a patient perspective, there were more severe reinterventions (limb amputation, graft infection, secondary ruptures, major redo procedures, and unclosed ostomies) in patients following open repair (19 of 248 vs 7 of 186; c 2 P ¼ .09). There were three secondary ruptures within 3 years of follow-up, all in EVAR patients. The influence of preoperative aortoiliac morphology on reintervention rates also will be reported.
Conclusions: After 3 years, the endovascular strategy emerges as the better care pathway for patients and does not appear to be associated with a greater rate of serious late reinterventions. Future reporting standards for ruptured aneurysm repair should include metrics such as amputation and graft infection (important to patients).
